# A Randomized Double Dummy Double Blind Dose Determining Place-bo Controlled Study to Evaluate Efficacy of Investigational Product E-RH-06 at 2 Dose Levels for the Metabolic Management of Chronic or Recurrent, Non-infective Nasal Congestion With-or-without Rhinorrhea.

> **NCT01546662** · NA · UNKNOWN · sponsor: **Enovate Biolife Pvt Ltd** · enrollment: 54 (estimated)

## Conditions studied

- Chronic Rhinitis

## Interventions

- **DIETARY_SUPPLEMENT:** E-RH-06
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT01546662
- **Lead sponsor:** Enovate Biolife Pvt Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-10
- **Primary completion:** 2012-05
- **Final completion:** 2012-06
- **Target enrollment:** 54 (ESTIMATED)
- **Last updated:** 2012-03-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01546662

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01546662, "A Randomized Double Dummy Double Blind Dose Determining Place-bo Controlled Study to Evaluate Efficacy of Investigational Product E-RH-06 at 2 Dose Levels for the Metabolic Management of Chronic or Recurrent, Non-infective Nasal Congestion With-or-without Rhinorrhea.". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT01546662. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*